Angiogenesis Inhibitors Are Safe Cancer Drugs Despite Hypertension Risk, Panel Concludes, University of Chicago Led Study

ScienceDaily (May 11, 2010) — A new class of cancer drugs can be used effectively while minimizing hypertensive side effects if patients’ blood pressure is closely monitored and controlled, a clinical panel has determined.

MORE ON THIS TOPIC